We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12B
AUM Growth
-$882M
Cap. Flow
-$307M
Cap. Flow %
-2.56%
Top 10 Hldgs %
23.8%
Holding
2,895
New
41
Increased
683
Reduced
1,007
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 13.65%
3 Financials 12.21%
4 Consumer Discretionary 10.98%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
176
Agilent Technologies
A
$41.9B
$11M 0.09%
90,482
-1,385
-2% -$178K
CTVA icon
177
Corteva
CTVA
$50.4B
$10.9M 0.09%
190,860
-4,115
-2% -$240K
ECL icon
178
Ecolab
ECL
$78.1B
$10.8M 0.09%
74,906
-1,006
-1% -$163K
MET icon
179
MetLife
MET
$61.4B
$10.8M 0.09%
177,876
-8,222
-4% -$525K
MRNA icon
180
Moderna
MRNA
$25.4B
$10.7M 0.09%
90,176
-3,843
-4% -$583K
HCA icon
181
HCA Healthcare
HCA
$89.8B
$10.6M 0.09%
57,775
-4,040
-7% -$805K
LHX icon
182
L3Harris
LHX
$54.1B
$10.6M 0.09%
50,814
-1,137
-2% -$262K
FCX icon
183
Freeport-McMoran
FCX
$96.9B
$10.4M 0.09%
379,485
-10,864
-3% -$318K
IQV icon
184
IQVIA
IQV
$39.8B
$10.4M 0.09%
57,182
-1,496
-3% -$328K
CHTR icon
185
Charter Communications
CHTR
$17.9B
$10.3M 0.09%
34,017
-1,921
-5% -$822K
PSX icon
186
Phillips 66
PSX
$90B
$10.3M 0.09%
127,688
-1,915
-1% -$163K
BIIB icon
187
Biogen
BIIB
$30.9B
$10.3M 0.09%
38,531
-907
-2% -$193K
CTAS icon
188
Cintas
CTAS
$81.4B
$10.2M 0.08%
104,776
-2,376
-2% -$243K
ROP icon
189
Roper Technologies
ROP
$39.1B
$10.1M 0.08%
28,131
-395
-1% -$161K
MNST icon
190
Monster Beverage
MNST
$90.1B
$10.1M 0.08%
464,380
+3,180
+0.7% +$73.3K
MCHP icon
191
Microchip Technology
MCHP
$43.1B
$10.1M 0.08%
165,411
-2,803
-2% -$184K
MSCI icon
192
MSCI
MSCI
$40.9B
$10M 0.08%
23,797
-440
-2% -$201K
MSI icon
193
Motorola Solutions
MSI
$77.7B
$9.91M 0.08%
44,251
-762
-2% -$180K
EXC icon
194
Exelon
EXC
$46.6B
$9.86M 0.08%
263,275
-777
-0.3% -$34.4K
CSL icon
195
Carlisle Companies
CSL
$15.2B
$9.82M 0.08%
35,011
-379
-1% -$109K
RMD icon
196
ResMed
RMD
$32.8B
$9.78M 0.08%
44,820
-466
-1% -$106K
FTNT icon
197
Fortinet
FTNT
$118B
$9.76M 0.08%
198,601
-5,805
-3% -$314K
HLT icon
198
Hilton Worldwide
HLT
$72.6B
$9.75M 0.08%
80,823
-2,184
-3% -$276K
HSY icon
199
Hershey
HSY
$37B
$9.75M 0.08%
44,216
-293
-0.7% -$65.7K
TT icon
200
Trane Technologies
TT
$105B
$9.73M 0.08%
67,162
-1,375
-2% -$205K

Similar funds

MetLife Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, MetLife Investment Management held 2,895 positions worth $12B, down 6.8% from $12.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. MetLife Investment Management opened 41 new positions and exited 96, leaving the 2,895-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q3 2022 buy was Aspen Technology Inc: 19,662 shares worth $4.68M.
  • MetLife Investment Management added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $24.5M increase.
  • MetLife Investment Management's biggest Q3 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $138M.
  • MetLife Investment Management fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.77M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12B portfolio in Q3 2022.
  • MetLife Investment Management opened 41 new positions and closed 96 in Q3 2022.
  • MetLife Investment Management's portfolio value fell 6.8% quarter-over-quarter to $12B.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.